Article Details

Revance Therapeutics (NASDAQ:RVNC) Downgraded by Zacks Investment Research to “Sell”

Retrieved on: 2022-05-14 16:29:55

Tags for this article:

Click the tags to see associated articles and topics

Revance Therapeutics (NASDAQ:RVNC) Downgraded by Zacks Investment Research to “Sell”. View article details on HISWAI: https://www.defenseworld.net/2022/05/14/revance-therapeutics-nasdaqrvnc-downgraded-by-zacks-investment-research-to-sell.html

Excerpt

According to Zacks, “Revance is a Silicon Valley-based biotechnology company. The company is developing a portfolio of products for aesthetic ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up